The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Presenilin1/γ‐secretase protects neurons from glucose deprivation‐induced death by regulating miR‐212 and PEA15
Abstract
Reduced cerebral glucose utilization is found in aged individuals and often is an early sign of neuro‐degeneration. Here, we show that under glucose deprivation (GD) conditions, decreased expression of presenilin 1 (PS1) results in decreased neuronal survival, whereas increased PS1 increases neuronal survival. Inhibition of γ‐secretase also decreases neuronal survival under GD conditions, which suggests the PS1/γ‐secretase system protects neurons from GD‐induced death. We also show that neuronal levels of the survival protein, phosphoprotein enriched in astrocytes at ∼15 kDa (PEA15), and its mRNA are regulated by PS1/γ‐secretase. Furthermore, down‐regulation of PEA15 decreases neuronal survival under reduced glucose conditions, whereas exogenous PEA15 increases neuronal survival even in the absence of PS1, which indicates that PEA15 promotes neuronal survival under GD conditions. The absence or reduction of PS1, as well as γ‐secretase inhibitors, increases neuronal miR‐212, which targets PEA15 mRNA. PS1/γ‐secretase activates the transcription factor, cAMP response element‐binding protein, regulating miR‐212, which targets PEA15 mRNA. Taken together, our data show that under conditions of reduced glucose, the PS1/γ‐secretase system decreases neuronal losses by suppressing miR‐212 and increasing its target survival factor, PEA15. These observations have implications for mechanisms of neuronal death under conditions of reduced glucose and may provide targets for intervention in neurodegenerative disorders.—Huang, Q., Voloudakis, G., Ren, Y., Yoon, Y., Zhang, E., Kajiwara, Y., Shao, Z., Xuan, Z., Lebedev, D., Georgakopoulos, A., Robakis, N. K. Presenilin1/γ‐secretase protects neurons from glucose deprivation‐induced death by regulating miR‐212 and PEA15. FASEB J. 32, 243‐253 (2018). www.fasebj.org
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Moreover, miR-212-5p was found decreased in several other neurodegenerative diseases such as AD, Huntington’s disease, and PD [62, 66, 69–75], indicating a key role in neurodegenerative diseases.”
From A role for astrocytic miR-129-5p in frontotemporal dementia (2025) · cites this paper as [62]
Citations
Cites
Synaptic versus extrasynaptic NMDA receptor signalling: implications for neurodegenerative disorders
Hardingham, G. E., & Bading, H. (2010) · Nature Reviews Neuroscience · doi:10.1038/nrn2911 · Cited by 1,644 · cited 1×
“Because CREB activity is regulated by NMDARs (42, 52), we asked whether the PS1/g-secretase systemmight affect CREB activity via this receptor.”
BackgroundReiman, E. M., Caselli, R. J., Yun, L. S., Chen, K., Bandy, D., Minoshima, S., Thibodeau, S. N., & Osborne, D. (1996) · New England Journal of Medicine · doi:10.1056/nejm199603213341202 · Cited by 1,366
A novel pathway regulates memory and plasticity via SIRT1 and miR-134
Gao, J., Wang, W.-Y., Mao, Y.-W., Gräff, J., Guan, J.-S., Pan, L., Mak, G., Kim, D., Su, S. C., & Tsai, L.-H. (2010) · Nature · doi:10.1038/nature09271 · Cited by 975
Flagged first, then by citations
Research works printed but not linked: 57
- Blum‐Degen D., 1995, Altered regulation of brain glucose metabolism as a cause of neurodegenerative disorders?, J. Neural Transm. Suppl., 46, 139
- 10.1196/annals.1427.007 · DOI
- 10.1186/1471-2202-9-S2-S16 · DOI · Paper page
- 10.1097/00002093-199505000-00005 · DOI
- 10.1016/0304-3940(95)11270-7 · DOI · Paper page
- Schöll M., 2011, Time course of glucose metabolism in relation to cognitive performance and postmortem neuropathology in Met146Val PSEN1 mutation carriers., J. Alzheimers Dis., 24, 495, 10.3233/JAD-2011-101563 · DOI
- 10.1523/JNEUROSCI.23-33-10681.2003 · DOI
- 10.1124/jpet.106.115550 · DOI
- 10.1371/journal.pone.0015008 · DOI · Paper page
- 10.1038/nrm1406 · DOI
- 10.1038/19077 · DOI
- 10.1523/JNEUROSCI.4067-07.2008 · DOI
- 10.1038/nature08177 · DOI
- Giannakopoulos P., 1997, Presenilin‐1‐immunoreactive neurons are preserved in late‐onset Alzheimer's disease., Am. J. Pathol., 150, 429
- 10.1016/j.neurobiolaging.2012.02.024 · DOI
- Mattson M. P., 2000, Presenilin‐1 mutation increases neuronal vulnerability to focal ischemia in vivo and to hypoxia and glucose deprivation in cell culture: involvementof perturbed calcium homeostasis., J. Neurosci., 20, 1358, 10.1523/JNEUROSCI.20-04-01358.2000 · DOI
- 10.1038/jcbfm.2010.101 · DOI
- 10.1084/jem.20070823 · DOI · Paper page
- 10.1111/j.1365-2990.2010.01076.x · DOI · Paper page
- 10.1016/j.brainres.2010.03.106 · DOI
- Smith P. Y., 2015, miR‐132/212 deficiency impairs tau metabolism and promotes pathological aggregation in vivo. Hum., Mol. Genet., 24, 6721
- 10.1038/emboj.2011.327 · DOI · Paper page
- 10.1016/j.pnpbp.2016.04.011 · DOI
- 10.1146/annurev.genom.8.080706.092351 · DOI
- 10.1093/emboj/21.8.1948 · DOI
- 10.1016/j.neurobiolaging.2011.06.017 · DOI
- 10.1158/0008-5472.CAN-04-0496 · DOI · Paper page
- Vandesompele J., 2002, Accurate normalization of real‐time quantitative RT‐PCR data by geometric averaging of multiple internal control genes., Genome Biol., 3, 10.1186/gb-2002-3-7-research0034 · DOI · Paper page
- Mosmann T., 1983, Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol., Methods, 65, 55
- 10.1096/fj.15-270645 · DOI
- 10.1073/pnas.1108225109 · DOI
- 10.1038/sj.emboj.7600251 · DOI
- 10.1083/jcb.149.4.793 · DOI
- 10.1158/0008-5472.CAN-09-3341 · DOI
- 10.1038/sj.onc.1210732 · DOI
- 10.1016/j.cell.2004.10.032 · DOI
- 10.1073/pnas.1015691107 · DOI · Paper page
- 10.1093/nar/gks151 · DOI
- 10.1016/S0896-6273(02)00828-0 · DOI · Paper page
- 10.1074/jbc.M113.499004 · DOI
- 10.1016/S1570-9639(02)00455-7 · DOI
- 10.1111/j.1749-6632.2000.tb05572.x · DOI
- 10.1002/1531-8249(200004)47:4<430::AID-ANA5>3.0.CO;2-I · DOI
- Leon M. J., 1993, The radiologic prediction of Alzheimer disease: the atrophic hippocampal formation., AJNRAm.J. Neuroradiol., 14, 897
- 10.1007/s004150050387 · DOI · Paper page
- 10.1073/pnas.061509598 · DOI · Paper page
- 10.1001/archneurol.2012.590 · DOI
- 10.1096/fj.11-183806 · DOI
- 10.1016/j.cell.2003.08.008 · DOI
- Xu J., 2009, Peptide EphB2/CTF2 generated by the gamma‐secretase processing of EphB2 receptor promotes tyrosine phosphorylation and cell surface localization of N‐methyl‐D‐aspartate receptors. J. Biol., Chem., 284, 27220
- Auffret A., 2010, Progressive age‐related impairment of the late long‐term po‐ tentiation in Alzheimer's disease presenilin‐1 mutant knock‐in mice., J. Alzheimers Dis., 19, 1021, 10.3233/JAD-2010-1302 · DOI
- 10.1523/JNEUROSCI.2474-10.2010 · DOI
- 10.1016/j.neurobiolaging.2007.10.009 · DOI
- Estelies A., 1999, The phosphoprotein protein PEA‐15 inhibits Fas‐ but increases TNF‐R1‐mediated caspase‐8 activity and apoptosis., Dev. Biol., 216, 16, 10.1006/dbio.1999.9510 · DOI
- 10.1152/ajpendo.00228.2009 · DOI
- 10.1523/JNEUROSCI.5572-05.2006 · DOI
- Ramos J. W., 2009, Deletion of PEA‐15 in mice is associated with specific impairments of spatial learning abilities., BMC Neurosci., 10, 134, 10.1186/1471-2202-10-134 · DOI
Cited by
Sorted by citations
A role for astrocytic miR-129-5p in frontotemporal dementia
Kaurani, L., Pradhan, R., Schröder, S., Burkhardt, S., Schuetz, A.-L., Krüger, D. M., Pena, T., Heutink, P., Sananbenesi, F., & Fischer, A. (2025) · Translational Psychiatry · doi:10.1038/s41398-025-03338-y · Cited by 10
Metadata
- Authors
- Huang, Q., Voloudakis, G., Ren, Y., Yoon, Y., Zhang, E., Kajiwara, Y., Shao, Z., Xuan, Z., Lebedev, D., Georgakopoulos, A., & Robakis, N. K.
- Affiliations
- Department of Psychiatry Icahn School of Medicine at Mount Sinai New York New York USA
- Venue
- The FASEB Journal
- Publisher
- Wiley
- Published
- 2017-08-30
- Volume
- 32
- Issue
- 1
- Pages
- 243-253
- ISSN
- 0892-6638
- 1530-6860
- Cited by
- 17
- References
- 3
- Language
- en
- Funders
- National Institutes of Health
- National Institute on Aging (AG17926, AG08200, AG05138)
- National Institute of Neurological Disorders and Stroke (NS047229)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review